Fubao Wang
Algemeen Adviseur bij PRIME MEDICINE, INC.
Profiel
Fubao Wang is a Senior VP & Head-Regulatory Affairs at Prime Medicine, Inc. He previously worked as a Director-Regulatory Affairs at Merck & Co., Inc., Vice President & Head-Regulatory at Sarepta Therapeutics, Inc., Associate Vice President at Sanofi, and Senior Vice President & Head-Regulatory Affairs at Asklepios BioPharmaceutical,.
Inc. Wang holds a doctorate from Ruprecht-Karls-Universität Heidelberg and undergraduate and graduate degrees from Nankai University.
Actieve functies van Fubao Wang
| Bedrijven | Functie | Begin |
|---|---|---|
| PRIME MEDICINE, INC. | Algemeen Adviseur | - |
Eerdere bekende functies van Fubao Wang
| Bedrijven | Functie | Einde |
|---|---|---|
| SANOFI | Corporate Officer/Principal | - |
| SAREPTA THERAPEUTICS, INC. | Algemeen Adviseur | - |
| MERCK & CO., INC. | Algemeen Adviseur | - |
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Algemeen Adviseur | - |
Opleiding van Fubao Wang
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
| Nankai University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| PRIME MEDICINE, INC. | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| SANOFI | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Asklepios BioPharmaceutical, Inc.
Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Health Technology |
